SNHG14 and ovarian carcinoma: Importantly, the expression level of SNHG14 has been demonstrated correlated with prognosis in patients with NSCLC (Zhang et al., 2019d), HCC (Zhang H. et al., 2020), ovarian cancer (Zhao J. L. et al., 2019), retinoblastoma (Sun et al., 2020), pancreatic ductal adenocarcinoma (Xie et al., 2020), colorectal cancer (Pei et al., 2019), cervical cancer (Ji et al., 2019), and endometrial cancer (Zhao et al., 2020).